OTCPK:RGEDF (Hungary)
Â
Ordinary Shares
$
39.59
-0.72 (-1.78%)
10:08 PM EST
Business Description
Chemical Works of Gedeon Richter PLC
ISIN : HU0000123096
Share Class Description:
RGEDF: Ordinary SharesTotal Employee Number:
11,955Compare
Compare
Traded in other countries / regions
RICHTER.Hungary0QFP.UKRIG2.GermanyRGEDF.USACHWGR.Luxembourg IPO Date
2007-11-09Description
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 9.9 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.15 | |||||
Interest Coverage | 26.18 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.43 | |||||
Beneish M-Score | -1.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.6 | |||||
3-Year EBITDA Growth Rate | 17.7 | |||||
3-Year EPS without NRI Growth Rate | 8.7 | |||||
3-Year FCF Growth Rate | 23.2 | |||||
3-Year Book Growth Rate | 10.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.85 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.48 | |||||
9-Day RSI | 53.23 | |||||
14-Day RSI | 51.16 | |||||
3-1 Month Momentum % | 25.97 | |||||
6-1 Month Momentum % | 33.6 | |||||
12-1 Month Momentum % | 43.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.37 | |||||
Quick Ratio | 3.17 | |||||
Cash Ratio | 1.45 | |||||
Days Inventory | 565.87 | |||||
Days Sales Outstanding | 191.05 | |||||
Days Payable | 145.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.33 | |||||
Dividend Payout Ratio | 0.72 | |||||
3-Year Dividend Growth Rate | 31.3 | |||||
Forward Dividend Yield % | 5.33 | |||||
5-Year Yield-on-Cost % | 33.93 | |||||
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | 6.55 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 69.67 | |||||
Operating Margin % | 33.78 | |||||
Net Margin % | 25.77 | |||||
EBITDA Margin % | 38.69 | |||||
FCF Margin % | 20.99 | |||||
OCF Margin % | 24.89 | |||||
ROE % | 8.99 | |||||
ROA % | 7.34 | |||||
ROIC % | 9.63 | |||||
3-Year ROIIC % | 32.71 | |||||
ROC (Joel Greenblatt) % | 21.08 | |||||
ROCE % | 10.34 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.44 | |||||
Forward PE Ratio | 8.47 | |||||
PE Ratio without NRI | 17.03 | |||||
Price-to-Owner-Earnings | 57.29 | |||||
PEG Ratio | 0.89 | |||||
PS Ratio | 4.79 | |||||
PB Ratio | 1.58 | |||||
Price-to-Tangible-Book | 2.08 | |||||
Price-to-Free-Cash-Flow | 22.67 | |||||
Price-to-Operating-Cash-Flow | 19.15 | |||||
EV-to-EBIT | 12.54 | |||||
EV-to-EBITDA | 10.51 | |||||
EV-to-Forward-EBITDA | 4.39 | |||||
EV-to-Revenue | 4.07 | |||||
EV-to-Forward-Revenue | 1.64 | |||||
EV-to-FCF | 19.38 | |||||
Price-to-GF-Value | 1.12 | |||||
Price-to-Projected-FCF | 1.25 | |||||
Price-to-DCF (Earnings Based) | 0.6 | |||||
Price-to-DCF (FCF Based) | 0.8 | |||||
Price-to-Median-PS-Value | 1.96 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.98 | |||||
Price-to-Graham-Number | 1.26 | |||||
| Price-to-Net-Current-Asset-Value | 4.61 | |||||
Earnings Yield (Greenblatt) % | 7.97 | |||||
FCF Yield % | 4.62 | |||||
Forward Rate of Return (Yacktman) % | 9.1 |
Chemical Works of Gedeon Richter PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chemical Works of Gedeon Richter PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| HUF 655.454500 Cash Dividend | 2026-06-03 | 41.79 (-4.19%) | ||
| HUF 509.000000 Cash Dividend | 2025-06-03 | 27.17 (+0.00%) | ||
| 10:1 Stock Split | 2013-07-11 | -- |
Show
Entries
Guru Commentaries on OTCPK:RGEDF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Chemical Works of Gedeon Richter PLC
No articles.